Effect of Memantine on Radiotherapy-related Cognitive Impairment

Summary

Purpose: This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the therapeutic effects of thalidomide in radiotherapy-related cognitive impairment. Further study details as provided by Sun Yat-sen Memorial Hospital, Sun Yat-sen University / Yameitang. Primary outcome measure: cognitive improvement, which is determined by the difference value of ADAS-cog score before and after the treatment of memantine.

Timeline

Start

2017-12-06

Primary completion

2024-10

Completion

2024-12

Drugs

Indications